Marlboro parent Altria is asking the Food and Drug Administration to help it spread the word that nicotine doesn't cause cancer.
If the FDA grants Pfizer's request, it could make it easier to distribute the vaccine across the U.S.
Johnson & Johnson applied for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine after releasing data last week showing it was about 66% effective in protecting against the virus. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joined "Squawk Box" on Friday to discuss.
Johnson & Johnson applied for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine after releasing data last week showing it was about 66% effective in protecting against the virus. CNBC's Meg Tirrell reports.
BlueNalu will use the funds to complete its regulatory review with the Food and Drug Administration and test its products in food service locations.
Abbott Labs is making its rapid Covid-19 antigen test available to schools, pharmacies and workplaces that require frequent and affordable testing.
Joe Urso, Activepure CEO, joins 'The Exchange' to discuss his company's emergency approval from the FDA for the company's air purifier products.
Sorrento Therapeutics is developing an antibodies injection and nose drops to fight Covid-19 and its variant strains.
Dr. Scott Gottlieb told CNBC on Friday that he expects a shortage of Covid-19 vaccine doses to continue past next week, even if the Food and Drug Administration issues emergency use authorization for Moderna's vaccine.
An FDA advisory panel voted to recommend the approval of Moderna's coronavirus vaccine for emergency use. CNBC's Meg Tirrell reports.
"Pfizer has got a different relationship with us. They're part of Operation Warp Speed. We have a $2 billion commitment for the first hundred million doses, but they've kept things more arm's length at their insistence throughout," Health and Human Services Secretary Alex Azar told CNBC's "Squawk Box" Thursday. "But we don't have complete visibility into their manufacturing because they have kept that a bit more arm's length."
Moderna's Covid vaccine could take a big step toward approval Thursday when an FDA advisory committee meets. CNBC's Meg Tirrell joins "Squawk Box" with a look at what to expect.
The staff of the Food and Drug Administration endorsed the emergency use of Moderna’s coronavirus vaccine in a report released Tuesday, a critical step forward in winning formal clearance to be administered to the public as early as next. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss.
The staff of the Food and Drug Administration endorsed the emergency use of Moderna’s coronavirus vaccine in a report released Tuesday, a critical step forward in winning formal clearance to be administered to the public as early as next week. CNBC's Meg Tirrell reports.
Pfizer's Covid vaccine, which has been approved for emergency-use by the FDA, is now being delivered across the United States. An estimated 2.9 million doses will be distributed by UPS and FedEx within a week. Vaccine shipments are getting priority access at airports. But states have only received $200 million from the CDC for distribution so far.
An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss.
CNBC's "Squawk on the Street" team discusses the FDA's review of the Pfizer vaccine for emergency use authorization with Fred Hassan, Caret Group chairman.
"There's a lot of people talking about stocks now like you haven't seen," CNBC's Jim Cramer said Friday. "Then there are a lot of people who don't have jobs and they're not talking about stocks. It's that so-called 'K' recovery."
The U.S. Food and Drug Administration is "rapidly" working toward clearing Pfizer's Covid-19 vaccine for emergency use after a key panel overwhelmingly endorsed the shots Thursday evening, Commissioner Stephen Hahn said in a statement on Friday. CNBC's Meg Tirrell reports.
An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. CNBC's Meg Tirrell reports.
